{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:06:30Z","timestamp":1784311590131,"version":"3.55.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100016237","name":"Armauer Hansen Research Institute","doi-asserted-by":"publisher","award":["TES2019"],"award-info":[{"award-number":["TES2019"]}],"id":[{"id":"10.13039\/100016237","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The development and spread of drug-resistant parasites continue to threaten progress toward malaria elimination. Therapeutic efficacy and molecular resistance marker studies are needed to guide national control programs. In African settings, evidence of partial resistance to artemisinin-based combination therapies (ACTs) associated with\n                      <jats:italic>Pfkelch13<\/jats:italic>\n                      mutations is accumulating, and World Health Organization (WHO) recommends regular monitoring of first line antimalarial drugs for early detection of resistant parasites. In this study, we evaluated the efficacy of artemether-lumefantrine (AL) combined with a single low dose of primaquine (PQ) for treating uncomplicated\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      malaria in a co-endemic area where\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      predominates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      One hundred twenty-three patients with\n                      <jats:italic>P. falciparum<\/jats:italic>\n                      mono-infection were enrolled between November 2020 to March 2021 and treated with artemether-lumefantrine (AL) plus a single low dose of primaquine (PQ) as per the national malaria treatment guideline and followed up for 28 days. Ethical approval was obtained from the AHRI\/ALERT ethics committee (Po\/23\/19), and the study was registered at Pan-African clinical trials registry (PACTR) with unique identification number of PACTR202509595696440.\n                      <jats:italic>Pfmsp2<\/jats:italic>\n                      capillary electrophoresis (CE) genotyping was used to differentiate recrudescence from new infections. More than half (56.1%) of the participants had high parasitemia (&gt;10,000 parasites\/\u03bcL) at enrollment. On day 3, 16.9% (20\/118) remained parasitemic, and of the 10 individuals with detectable gametocytes at enrollment, only 3.4% remained gametocytemic on day 3, and 100% parasite clearance was observed on day 7, respectively. Multiplicity of infection was 3.8 at enrollment and 1.7 at the time of recurrence. The adequate clinical and parasitological responses at 28-day (ACPR) of per protocol analysis (PPA) was 73.7% for PCR-uncorrected and 91.3% for PCR-corrected, respectively and while, the intention-to-treat analysis (ITA), the Kaplan\u2013Meier estimated treatment success at day 28 was 93.2% (95% CI: 88.5\u201398.2) after PCR correction, compared with 78.3% (95% CI: 71.0\u201386.4) in the PCR-uncorrected analysis. In our study assessment, no cases of severe malaria or serious adverse events occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The efficacy observed in this study, although remaining above the WHO policy change threshold after PCR correction, may indicate a potential decline in AL\u2019s effectiveness in this high transmission setting. However, because antimalarial drug concentrations were not measured and evening doses were not fully directly observed, reduced drug exposure or imperfect adherence cannot be excluded as possible contributors to the observed treatment outcomes Therefore, we suggest regular therapeutic efficacy monitoring and further investigation using advanced molecular techniques, such as next-generation sequencing (NGS), to enable early detection of resistance-associated parasite variants that may compromise treatment efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0335833","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:56:21Z","timestamp":1784310981000},"page":"e0335833","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic efficacy of artemether-lumefantrine plus single low dose primaquine for the treatment of uncomplicated Plasmodium falciparum malaria in a high transmission setting, Western Ethiopia"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1359-6165","authenticated-orcid":true,"given":"Jimma Dinsa","family":"Deressa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinknesh Wolde","family":"Behaksra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshetu","family":"Molla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemayehu","family":"Letebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girma","family":"Shumie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethlehem","family":"Adnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit Hailu","family":"Alemayehu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikregabrail Aberra","family":"Kassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamrayehu","family":"Seyoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7609-2382","authenticated-orcid":true,"given":"Elias B.","family":"Tafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kidist","family":"Woldekidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Legesse Alamerie","family":"Ejigu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Huwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Migbaru","family":"Keffale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudissa Assefa","family":"Bayissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Koepfli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayissa","family":"Chala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehenew","family":"Asmamaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fitsum Girma","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalamaw","family":"Gadisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"pone.0335833.ref001","volume-title":"Malaria Diagnosis and Treatment Guidelines for Health Workers in Ethiopia","author":"FMoH","year":"2004"},{"issue":"1","key":"pone.0335833.ref002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12936-021-03745-8","article-title":"Efficacy and safety of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Ethiopia: a systematic review and meta-analysis","volume":"20","author":"A Abamecha","year":"2021","journal-title":"Malar J"},{"key":"pone.0335833.ref003","volume-title":"World malaria report 2025: Addressing the threat of antimalarial drug resistance","author":"WHO","year":"2025"},{"key":"pone.0335833.ref004","volume-title":"World malaria report 2023","author":"WHO","year":"2023"},{"issue":"1","key":"pone.0335833.ref005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40249-016-0151-8","article-title":"Malaria: Global progress 2000 \u2013 2015 and future challenges","volume":"5","author":"RE Cibulskis","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"pone.0335833.ref006","volume-title":"National malaria elimination strategic plan (2024\/25-2026\/27)","author":"Control D","year":"2023"},{"key":"pone.0335833.ref007","volume-title":"World malaria report 2022","author":"WHO","year":"2022"},{"issue":"7","key":"pone.0335833.ref008","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/cid\/ciac162","article-title":"Circulation of an Artemisinin-Resistant Malaria Lineage in a Traveler Returning from East Africa to France","volume":"75","author":"R Copp\u00e9e","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pone.0335833.ref009","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"A Uwimana","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"pone.0335833.ref010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4269\/ajtmh.14-0031","article-title":"Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine","volume":"91","author":"M Venkatesan","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0335833.ref011","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1475-2875-11-176","article-title":"Artemether-lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania","volume":"11","author":"A F\u00e4rnert","year":"2012","journal-title":"Malar J"},{"issue":"6","key":"pone.0335833.ref012","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem)","volume":"191","author":"C Sisowath","year":"2005","journal-title":"J Infect Dis"},{"issue":"12","key":"pone.0335833.ref013","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AAC.00638-09","article-title":"In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1","volume":"53","author":"L Mwai","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0335833.ref014","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4269\/ajtmh.15-0477","article-title":"A Unique Plasmodium falciparum K13 Gene Mutation in Northwest Ethiopia","volume":"94","author":"AG Bayih","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"pone.0335833.ref015","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","article-title":"Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia","volume":"8","author":"AA Fola","year":"2023","journal-title":"Nat Microbiol"},{"issue":"4","key":"pone.0335833.ref016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231866","article-title":"geoBoundaries: A global database of political administrative boundaries","volume":"15","author":"D Runfola","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pone.0335833.ref017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12936-021-03629-x","article-title":"Detection of high prevalence of Plasmodium falciparum histidine-rich protein 2\/3 gene deletions in Assosa zone, Ethiopia: implication for malaria diagnosis","volume":"20","author":"GS Alemayehu","year":"2021","journal-title":"Malar J"},{"key":"pone.0335833.ref018","unstructured":"U.S. President\u2019s Malaria Initiative. Ethiopia Malaria Operational Plan FY 2022. 2022."},{"key":"pone.0335833.ref019","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009"},{"key":"pone.0335833.ref020","volume-title":"Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010-2019)","author":"World Health Organization","year":"2020"},{"key":"pone.0335833.ref021","unstructured":"Ministry of Health E. National malaria elimination program (NMEP). 2024."},{"key":"pone.0335833.ref022","volume-title":"National malaria guidelines","author":"Disease Prevention and Control","year":"2018","edition":"4"},{"key":"pone.0335833.ref023","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2875-12-6","article-title":"Diagnostic performance of CareStart\u2122 malaria HRP2\/pLDH (Pf\/pan) combo test versus standard microscopy on falciparum and vivax malaria between China-Myanmar endemic borders","volume":"12","author":"S Xiaodong","year":"2013","journal-title":"Malar J"},{"key":"pone.0335833.ref024","first-page":"189","article-title":"Nested PCR analysis of Plasmodium parasites","volume":"72","author":"G Snounou","year":"2002","journal-title":"Methods in Molecular Medicine"},{"key":"pone.0335833.ref025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1475-2875-6-112","article-title":"Comparison of PCR-based detection of Plasmodium falciparum infections based on single and multicopy genes","volume":"6","author":"SI Oyedeji","year":"2007","journal-title":"Malar J"},{"key":"pone.0335833.ref026","unstructured":"World Health Organization. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. 2008."},{"key":"pone.0335833.ref027","unstructured":"Organization WH. Methods for surveillance of antimalarial drug efficacy. 2009."},{"key":"pone.0335833.ref028","volume-title":"Methods for surveillance of antimalarial drug efficacy","author":"WHO","year":"2009"},{"issue":"9","key":"pone.0335833.ref029","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1365-3156.2006.01688.x","article-title":"Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness","volume":"11","author":"K Mugittu","year":"2006","journal-title":"Trop Med Int Health"},{"key":"pone.0335833.ref030","volume-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity","author":"WHO","year":"2011"},{"issue":"16","key":"pone.0335833.ref031","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/febs.14127","article-title":"Combating multidrug-resistant Plasmodium falciparum malaria","volume":"284","author":"AM Thu","year":"2017","journal-title":"FEBS J"},{"key":"pone.0335833.ref032","volume-title":"Informal consultation on methodology to distinguish reinfection from recrudescence in high malaria transmission areas: report of a virtual meeting, 17\u201318 May 2021","author":"WHO","year":"2021"},{"issue":"9","key":"pone.0335833.ref033","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1128\/AAC.00159-07","article-title":"Impact of transmission intensity on the accuracy of genotyping to distinguish recrudescence from new infection in antimalarial clinical trials","volume":"51","author":"B Greenhouse","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"pone.0335833.ref034","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12936-022-04350-z","article-title":"Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia","volume":"21","author":"A Assefa","year":"2022","journal-title":"Malar J"},{"issue":"9","key":"pone.0335833.ref035","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00002-22","article-title":"Persistence of Residual Submicroscopic P. falciparum Parasitemia following Treatment of Artemether-Lumefantrine in Ethio-Sudan Border, Western Ethiopia","volume":"66","author":"G Tadele","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0335833.ref036","doi-asserted-by":"crossref","first-page":"107800","DOI":"10.1016\/j.actatropica.2025.107800","article-title":"Efficacy and gametocyte carriage in Plasmodium falciparum cases treated with artemether-lumefantrine alone versus with single-dose primaquine in Ethiopia: A randomized controlled study","volume":"270","author":"T Kumsa","year":"2025","journal-title":"Acta Trop"},{"issue":"1","key":"pone.0335833.ref037","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12936-024-05087-7","article-title":"Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Arba Minch Zuria District, Gamo Zone, Southwest Ethiopia","volume":"23","author":"D Daka","year":"2024","journal-title":"Malar J"},{"issue":"4","key":"pone.0335833.ref038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176004","article-title":"Therapeutic efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in a high-transmission area in northwest Ethiopia","volume":"12","author":"M Teklemariam","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"pone.0335833.ref039","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/infdis\/jiaa498","article-title":"Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis","volume":"225","author":"K Stepniewska","year":"2022","journal-title":"J Infect Dis"},{"key":"pone.0335833.ref040","author":"T Kumsa","journal-title":"Artemether-Lumefantrine Alone Versus with Primaquine: Efficacy and Low Gametocyte Carriage in Plasmodium Falciparum Cases in Arba Minch, Ethiopia"},{"key":"pone.0335833.ref041","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1475-2875-10-278","article-title":"The parasite clearance curve","volume":"10","author":"NJ White","year":"2011","journal-title":"Malar J"},{"issue":"1","key":"pone.0335833.ref042","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12936-022-04304-5","article-title":"High prevalence of Pfcrt 76T and Pfmdr1 N86 genotypes in malaria infected patients attending health facilities in East Shewa zone, Oromia Regional State, Ethiopia","volume":"21","author":"J Hassen","year":"2022","journal-title":"Malar J"},{"issue":"10","key":"pone.0335833.ref043","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/tmi.13929","article-title":"Antimalarial drug efficacy and resistance in malaria-endemic countries in HANMAT-PIAM_net countries of the Eastern Mediterranean Region 2016-2020: Clinical and genetic studies","volume":"28","author":"M Adam","year":"2023","journal-title":"Trop Med Int Health"},{"issue":"1","key":"pone.0335833.ref044","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s43856-025-01008-0","article-title":"Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia","volume":"5","author":"BG Brhane","year":"2025","journal-title":"Commun Med (Lond)"},{"issue":"8","key":"pone.0335833.ref045","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1086\/501473","article-title":"Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda","volume":"193","author":"SA Lee","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0335833.ref046","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41598-018-36493-y","article-title":"Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans","volume":"9","author":"P Sondo","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0335833.ref047","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpara.2004.10.014","article-title":"Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan","volume":"35","author":"E Nassir","year":"2005","journal-title":"Int J Parasitol"},{"issue":"6","key":"pone.0335833.ref048","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/genes10060434","article-title":"The Diversity, Multiplicity of Infection and Population Structure of P. falciparum Parasites Circulating in Asymptomatic Carriers Living in High and Low Malaria Transmission Settings of Ghana","volume":"10","author":"Z Abukari","year":"2019","journal-title":"Genes (Basel)"},{"issue":"1","key":"pone.0335833.ref049","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4269\/ajtmh.15-0477","article-title":"A Unique Plasmodium falciparum K13 Gene Mutation in Northwest Ethiopia","volume":"94","author":"AG Bayih","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"pone.0335833.ref050","doi-asserted-by":"crossref","unstructured":"Alemayehu AA, Castaneda-Mogollon D, Tesfa H, Getie S, Mohon AN, Balasingam N. Expansion of the Plasmodium falciparum Kelch 13 R622I mutation in Northwest Ethiopia. 2021.","DOI":"10.21203\/rs.3.rs-171038\/v1"},{"issue":"13","key":"pone.0335833.ref051","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","article-title":"Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea","volume":"389","author":"S Mihreteab","year":"2023","journal-title":"N Engl J Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:56:36Z","timestamp":1784310996000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335833"}},"subtitle":[],"editor":[{"given":"David J.","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335833","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]}}}